Arquivamento definitivo - Art. 33 da LPI
#11.1.1
05/02/2023
RPI 2730
Application data
Number
112021008041Type
Filing
Publication
PCT
IB2019001194 The application was abandoned: examination was not requested within the 36 months following the 11/07/2019 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 05/02/2023. We update with every new RPI gazette, published weekly.
Applicants
CRISPR THERAPEUTICS AG
CH
Inventors
D. K. (pessoa física)
US
J. S. (pessoa física)
US
J. T. (pessoa física)
US
IPC Classification
Priority claims
US
62/756,718 · 11/07/2018
US
62/767,388 · 11/14/2018
US
62/767,395 · 11/14/2018
US
62/826,643 · 03/29/2019
US
62/826,648 · 03/29/2019
Abstract
TERAPIA CONTRA O CÂNSER COM CÉLULAS IMUNITÁRIAS ANTI-CD33.A presente invenção refere-se a métodos e composições (por exemplo, composições celulares) para o tratamento de câncer, tal como malignidades CD33+.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.1.1
05/02/2023
RPI 2730
#11.1
02/14/2023
RPI 2719
#1.3
08/10/2021
RPI 2640
#1.1
05/04/2021
RPI 2626
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.